News summaryNetEase FinanceNov 8, 2026, 12:46 PM
Isomorphic Labs reportedly seeks $5B in new funding
Isomorphic Labs is reportedly in talks for about $5 billion in new financing. [[fact-4vqs5t2gp]]If completed, the financing could value the company at $50 billion. [[fact-i36vsjsj6]]The company has not yet had a drug enter human clinical trials. [[fact-99nnw7a58]]It expects to begin its first human clinical trial by the end of 2026. [[fact-5m8ulwxir]]An Isomorphic Labs report says IsoDDE's structure-prediction accuracy on the Runs N'Poses benchmark exceeded AlphaFold 3's by more than twofold. [[fact-1obb7hx9l]]Mohammed AlQuraishi said the report lacked enough technical detail for outsiders to independently reproduce the results. [[fact-hj5ftqu6r]]